Assessment of BCR-ABL1 transcript levels at 3 months is the only requirement for predicting outcome for patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Richard Szydlo Gareth Gerrard |
| Publication date | November 7, 2011 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |